Surgepays, Inc. current report, 19 January 2021

Business Context and Reporting Period

This Form 8-K was filed by SurgePays, Inc. on January 25, 2021, reporting events occurring on January 19, 2021. The filing details the resolution of litigation styled as AltCorp Trading, LLC, et al. v. Surge Holdings, Inc. through a Mutual Release and Settlement Agreement that became fully effective upon court dismissal on January 19, 2021.

Key Financial Metrics and Transaction Terms

  • Settlement Value: The Company agreed to pay $3,300,000 in Common Stock to resolve the claims.
  • Payment Structure: The payment will be made in monthly installments of $100,000 worth of Common Stock over 32 months, commencing January 8, 2021.
  • Valuation Method: Share quantities are calculated based on the volume weighted average price (VWAP) of the Common Stock during the 10 trading days preceding the 3 trading days before the first trading day of each calendar month.
  • Initial Issuance: On January 13, 2021, the Company issued 850,557 shares to AltCorp, representing less than 1% of shares outstanding as of the November 16, 2020 10-Q.
  • Share Reserve: The Company increased its reserved share quantity from 22,000,000 to 33,000,000 shares to satisfy the settlement and potential "True-Up" obligations.
  • Cash Option: The Company retains the option to pay a portion of the settlement in cash, though the primary mechanism is stock issuance.

Material Changes and Background

This filing resolves a dispute stemming from a June 29, 2020 agreement where the Company exchanged $2,750,000 of principal (plus interest, fees, and expenses) of a promissory note held by AltCorp for 5,500,000 shares of Common Stock. The new settlement increases the total obligation to $3,300,000 and extends the share reserve commitment for 32 months. The filing does not provide specific revenue, profit, cash flow, or debt figures for the reporting period, as it focuses solely on the settlement agreement.

Outlook, Risks, and Contingencies

  • Dilution Risk: The settlement requires the issuance of shares over 32 months, creating ongoing dilution for existing shareholders dependent on the Company's stock price.
  • Share Reserve Constraint: The Company is restricted from decreasing the 33,000,000 share reserve for 32 months, except to satisfy obligations under this agreement.
  • Price Sensitivity: The number of shares issued monthly is inversely related to the stock price; lower stock prices will result in higher share issuance volumes to meet the $100,000 monthly value target.

Investor Verification Checklist

  • Verify the exact number of shares issued in subsequent monthly installments and the corresponding VWAP used for calculation.
  • Review the full text of the Mutual Release and Settlement Agreement (Exhibit 10.1) for specific terms regarding the cash payment option.
  • Monitor the Company's total authorized and outstanding share count to assess the cumulative dilution impact of the 33,000,000 share reserve.
  • Confirm whether any cash payments were utilized in lieu of stock issuance in the first few months of the agreement.